• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Longer and more frequent napping among older individuals is associated with increased mortality

bySiwen LiuandSimon Pan
May 4, 2026
in Chronic Disease
Reading Time: 2 mins read
Decline in adolescent sleep duration over past 20 years
Share on FacebookShare on Twitter

1. Older individuals with actigraphy-assessed longer nap duration, more frequent naps, and a tendency to nap in the morning was associated with a higher all-cause mortality.

Evidence Rating Level: 2 (Good)

Excessive napping in late life is associated with adverse health outcomes including mortality. As previous studies mainly relied on self-reported napping habits, objective measurements are needed for more reliable findings. There also lacks research on some daytime nap characteristics, such as timing and variability of nap duration across days. This study thus examined whether actigraphy-measured daytime nap duration, frequency, variability, and timing were associated with all-cause mortality. This prospective cohort study used data from the Rush Memory and Aging Project and included community-dwelling adults aged >56 years in the U.S., with up to 19 years of follow-up. The analytic baseline was initiated in August 2005. Participants wore the actigraphy device continuously for up to 14 days. The primary outcome was daytime napping, defined as sleep episodes between 9 am and 7 pm. Participants were categorized as morning nappers (peak window: 9 am to 12 pm or 10 am to 1 pm), early afternoon nappers (peak window: 11 am to 2 pm, 12-3 pm, 1-4 pm, or 2-5 pm), or late afternoon nappers (peak window: 3-6 pm or 4-7 pm). In total, 1,338 participants (mean [SD] age, 81.4 [7.4] years; 1018 [76.0%] female) were included over a mean (SD) follow-up of 8.3(4.78) years. At a mean (SD) of 7.54 (4.52) years after analytic baseline, 926 (69.2%) deaths were reported. Longer daytime nap duration (adjusted hazard ratio [AHR] per 1-hour increase, 1.13; 95% CI, 1.04-1.23) and higher nap frequency (AHR per additional daily nap, 1.07; 95% CI, 1.02-1.13) at baseline were associated with a 13% and 7% increased risk of mortality, respectively. The risk of mortality was higher among morning nappers compared with early afternoon nappers (AHR, 1.30; 95% CI, 1.03-1.64). There was no association between variability in daytime nap duration and mortality (AHR per 1-hour increase, 1.01; 95% CI, 0.89-1.14). Overall, this study found that older individuals with longer nap duration, more frequent naps, and a tendency to nap in the morning was associated with a higher all-cause mortality. These findings highlight the potential of wearable device-based daytime nap assessments in identifying high-risk individuals for sleep interventions to improve sleep health and longevity.

Click here to read the study in JAMA Network Open

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Prognostic associations of anthropometric indices vary by clinical outcomes

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

2 Minute Medicine Rewind September 21, 2026

Tags: all-cause mortalitynappingolder adultssleepsleep disorder
Previous Post

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

Next Post

2 Minute Medicine Rewind May 4, 2026

RelatedReports

Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Cardiology

Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases

September 23, 2026
Weekly Rewinds

2 Minute Medicine Rewind September 21, 2026

September 21, 2026
Pharma

First messenger RNA influenza vaccine outperforms standard-dose vaccination

September 15, 2026
Next Post
Systematic review examines benefits and adverse effects of cannabinoid therapy

2 Minute Medicine Rewind May 4, 2026

Combined MRI and NIH stroke scores may predict stroke prognosis

Triple low-dose antihypertensive pill reduced recurrent stroke after intracerebral hemorrhage

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Nirmatrelvir–ritonavir does not improve severe outcomes in adults vaccinated against COVID-19

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training
  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.